Rojas RI, Rodríguez JY, Padilla GCM, Miqueli RM, González PB, Vigoa AL

Language: Spanish
References: 0
Page: 1-9
PDF size: 88.79 Kb.

ABSTRACT

Objective: to evaluate the therapeutic results of the application of toxin botulínica A in patients with palpebral spastic alterations.
Methods: an observational, descriptive, longitudinal and prospective study was performed on 18 patients with these conditions, who were selected at the Oculoplasty Service of "Ramón Pando Ferrer" Cuban Institute of Ophthalmology in the period from January to December 2016. The analyzed variables were age, sex, race, personal pathological history, eyelid disorders and restricted daily life. In the postoperative period, length of time for symptom relief, duration of the effect of botulinum toxin injection, and immediate and mediate complications were assessed.
Results: in the group, 70,6 % were included in the over 60 y age group and 52,9 % were women. Caucasians accounted for 58,8 % of the sample. The most frequent condition was blepharospasm (47,1 %). All patients had limitations to perform daily life tasks. In 94,1 % of the patients, involuntary movements disappeared between the 4th and the 5th day after the administration of Xeomeen and in 88,2 %, the symptoms delayed to appear again from 4 to 6 months.
Conclusions: botulinum toxin A is an effective alternative to correct palpebral spastic conditions, with symptoms disappearing in four to five days, and quick reincorporation of the patient to working and social life for 4 to 6 months.